Annual Working Capital
$647.02 M
+$58.28 M+9.90%
31 December 2023
Summary:
Pacific Biosciences of California annual working capital is currently $647.02 million, with the most recent change of +$58.28 million (+9.90%) on 31 December 2023. During the last 3 years, it has risen by +$329.93 million (+104.05%). PACB annual working capital is now -37.15% below its all-time high of $1.03 billion, reached on 31 December 2021.PACB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$524.24 M
-$25.51 M-4.64%
30 September 2024
Summary:
Pacific Biosciences of California quarterly working capital is currently $524.24 million, with the most recent change of -$25.51 million (-4.64%) on 30 September 2024. Over the past year, it has dropped by -$174.10 million (-24.93%). PACB quarterly working capital is now -54.89% below its all-time high of $1.16 billion, reached on 31 March 2021.PACB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.9% | -24.9% |
3 y3 years | +104.0% | -51.2% |
5 y5 years | +517.5% | +1897.3% |
PACB Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -37.1% | +104.0% | -51.2% | at low |
5 y | 5 years | -37.1% | +1928.7% | -54.9% | +2511.1% |
alltime | all time | -37.1% | +1928.7% | -54.9% | +2511.1% |
Pacific Biosciences Of California Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $524.24 M(-4.6%) |
June 2024 | - | $549.75 M(-9.0%) |
Mar 2024 | - | $604.07 M(-6.6%) |
Dec 2023 | $647.02 M(+9.9%) | $647.02 M(-7.3%) |
Sept 2023 | - | $698.34 M(+5.1%) |
June 2023 | - | $664.14 M(-7.2%) |
Mar 2023 | - | $715.44 M(+21.5%) |
Dec 2022 | $588.74 M(-42.8%) | $588.74 M(-29.3%) |
Sept 2022 | - | $832.25 M(-6.1%) |
June 2022 | - | $885.89 M(-8.5%) |
Mar 2022 | - | $968.18 M(-5.9%) |
Dec 2021 | $1.03 B(+224.7%) | $1.03 B(-4.2%) |
Sept 2021 | - | $1.07 B(-6.1%) |
June 2021 | - | $1.14 B(-1.6%) |
Mar 2021 | - | $1.16 B(+266.5%) |
Dec 2020 | $317.08 M(+894.2%) | $317.08 M(+190.3%) |
Sept 2020 | - | $109.24 M(+444.1%) |
June 2020 | - | $20.08 M(-46.5%) |
Mar 2020 | - | $37.56 M(+17.8%) |
Dec 2019 | $31.89 M(-69.6%) | $31.89 M(+21.5%) |
Sept 2019 | - | $26.25 M(-46.9%) |
June 2019 | - | $49.46 M(-26.7%) |
Mar 2019 | - | $67.49 M(-35.6%) |
Dec 2018 | $104.78 M(+43.6%) | $104.78 M(-14.3%) |
Sept 2018 | - | $122.22 M(+64.8%) |
June 2018 | - | $74.15 M(-18.3%) |
Mar 2018 | - | $90.75 M(+24.3%) |
Dec 2017 | $72.98 M | $72.98 M(-12.4%) |
Sept 2017 | - | $83.32 M(-14.3%) |
June 2017 | - | $97.24 M(+83.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2017 | - | $52.90 M(-29.7%) |
Dec 2016 | $75.24 M(+4.0%) | $75.24 M(-16.7%) |
Sept 2016 | - | $90.36 M(-13.3%) |
June 2016 | - | $104.24 M(+19.8%) |
Mar 2016 | - | $87.04 M(+20.3%) |
Dec 2015 | $72.36 M(-16.1%) | $72.36 M(+52.5%) |
Sept 2015 | - | $47.45 M(-7.3%) |
June 2015 | - | $51.17 M(-16.3%) |
Mar 2015 | - | $61.11 M(-29.2%) |
Dec 2014 | $86.27 M(-17.0%) | $86.27 M(+1.5%) |
Sept 2014 | - | $85.00 M(-7.5%) |
June 2014 | - | $91.93 M(-16.1%) |
Mar 2014 | - | $109.55 M(+5.4%) |
Dec 2013 | $103.90 M(+3.6%) | $103.90 M(-12.9%) |
Sept 2013 | - | $119.28 M(+11.5%) |
June 2013 | - | $107.02 M(-5.2%) |
Mar 2013 | - | $112.90 M(+12.6%) |
Dec 2012 | $100.26 M(-44.4%) | $100.26 M(-15.5%) |
Sept 2012 | - | $118.71 M(-13.8%) |
June 2012 | - | $137.72 M(-12.3%) |
Mar 2012 | - | $157.01 M(-12.9%) |
Dec 2011 | $180.22 M(-33.8%) | $180.22 M(-9.5%) |
Sept 2011 | - | $199.15 M(-10.8%) |
June 2011 | - | $223.26 M(-7.0%) |
Mar 2011 | - | $240.14 M(-11.8%) |
Dec 2010 | $272.27 M(+219.1%) | $272.27 M(+188.5%) |
Sept 2010 | - | $94.37 M(-23.8%) |
June 2010 | - | $123.90 M(+45.2%) |
Dec 2009 | $85.33 M(-16.5%) | $85.33 M |
Dec 2008 | $102.22 M | - |
FAQ
- What is Pacific Biosciences of California annual working capital?
- What is the all time high annual working capital for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual working capital year-on-year change?
- What is Pacific Biosciences of California quarterly working capital?
- What is the all time high quarterly working capital for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly working capital year-on-year change?
What is Pacific Biosciences of California annual working capital?
The current annual working capital of PACB is $647.02 M
What is the all time high annual working capital for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual working capital is $1.03 B
What is Pacific Biosciences of California annual working capital year-on-year change?
Over the past year, PACB annual working capital has changed by +$58.28 M (+9.90%)
What is Pacific Biosciences of California quarterly working capital?
The current quarterly working capital of PACB is $524.24 M
What is the all time high quarterly working capital for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly working capital is $1.16 B
What is Pacific Biosciences of California quarterly working capital year-on-year change?
Over the past year, PACB quarterly working capital has changed by -$174.10 M (-24.93%)